Antibiotic Treatment Duration for Acute Cholecystitis Without Surgery

Treatment Duration Based on Patient Status

The World Journal of Emergency Surgery recommends antibiotic therapy for no more than 7 days in immunocompetent patients and up to 7 days in immunocompromised or critically ill patients 1, 2
For immunocompetent patients, antibiotic therapy should be limited to a maximum of 7 days, and patients who show clinical improvement may have antibiotics discontinued after 4 days 1, 2, 3, 4
Continuing antibiotics beyond 7 days without clinical improvement warrants further diagnostic investigation in all patient groups 1

First-line options for non-critically ill, immunocompetent patients include Amoxicillin/Clavulanate and alternatives for beta-lactam allergies such as Eravacycline or Tigecycline 1, 5
For critically ill or immunocompromised patients, options include Piperacillin/tazobactam and Eravacycline for beta-lactam allergies 1, 5

Percutaneous cholecystostomy should be considered for critically ill patients with multiple comorbidities who are unfit for surgery, and for patients who do not show clinical improvement after 3-5 days of antibiotic therapy 3, 4

Clinical response should be evaluated through vital signs, laboratory values, and symptom improvement, and patients with persistent signs of infection require additional imaging studies 1, 6

Broad-spectrum antibiotics should not be continued after they are no longer required to minimize antibiotic resistance 4

Continuing antibiotics beyond 7 days without investigating for complications or alternative diagnoses, and failing to consider percutaneous drainage in patients who don't respond to antibiotic therapy 1, 3, 4

Management of acute cholecystitis with cholecystostomy drain should involve multidisciplinary consultation with infectious disease specialists, particularly for immunocompromised or critically ill patients 7
In patients who don't respond to antibiotic therapy within 3-5 days, consider drain repositioning or replacement to ensure adequate source control 7
Avoid using broad-spectrum antibiotics longer than necessary to prevent antibiotic resistance, as narrow-spectrum antibiotics can achieve comparable outcomes in moderate acute cholecystitis after cholecystostomy 7